Abbott Laboratories
ABT
105.25
+1.19
+1.14%
Abbott Laboratories
US · ABT
#113 by market cap
Listed 1970
105.25
+1.19
+1.14%
Live - 5344 symbols - heartbeat 51s ago
· 2026-10-20 09:30
Analyst consensus 14 analysts
Buy
Avg price target 125.50 +19.2%
Price target rangecurrent 105.25
Low112.00
Avg125.50
High135.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-07 | J.P. Morgan | -- | Buy | 120.00 |
| 2026-10-05 | Wells Fargo | -- | Buy | 112.00 |
| 2026-10-05 | Citi | -- | Buy | 125.00 |
| 2026-10-02 | Rothschild & Co Redburn | -- | Buy | 127.00 |
| 2026-10-01 | BofA Securities | -- | Buy | 115.00 |
| 2026-10-01 | RBC Capital | -- | Buy | 130.00 |
| 2026-09-29 | Wells Fargo | -- | Buy | 112.00 |
| 2026-09-14 | TD Cowen | -- | Buy | 135.00 |
| 2026-09-10 | Citi | -- | Buy | 125.00 |
| 2026-09-08 | Wells Fargo | -- | Buy | 112.00 |
| 2026-09-01 | J.P. Morgan | -- | Buy | -- |
| 2026-08-31 | TD Cowen | -- | Buy | 135.00 |
| 2026-08-30 | TD Cowen | -- | Buy | 135.00 |
| 2026-08-26 | Piper Sandler | -- | Buy | 118.00 |
| 2026-08-21 | TD Cowen | -- | Buy | 135.00 |
| 2026-08-21 | William Blair | -- | Buy | -- |
| 2026-08-21 | Jefferies | -- | Buy | 135.00 |
| 2026-08-20 | BTIG | -- | Buy | 134.00 |
| 2026-08-20 | BofA Securities | -- | Buy | 115.00 |
| 2026-08-14 | Citi | -- | Buy | 125.00 |
| 2026-08-13 | Wolfe Research | -- | Buy | 130.00 |
| 2026-08-11 | BofA Securities | -- | Buy | 115.00 |
| 2026-08-04 | Citi | -- | Buy | -- |
| 2026-07-28 | TD Cowen | -- | Buy | 115.00 |
| 2026-07-28 | UBS | -- | Buy | 125.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Wolfe Research moved from Hold to Buy on 2026-08-13.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-13 | Wolfe Research | Hold → Buy | 130.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-16 | -- | ±4.61% | +10.71% (beat) |
| 2026/Q1 | 2026-04-16 | -- | ±4.59% | -6.00% (beat) |
| 2025/Q4 | 2026-01-22 | -- | ±3.36% | -10.04% (beat) |
| 2025/Q3 | 2025-10-15 | -- | ±3.53% | -2.43% (in line) |
| 2025/Q2 | 2025-07-17 | -- | ±3.56% | -8.52% (beat) |
| 2025/Q1 | 2025-04-16 | -- | ±3.80% | +2.76% (in line) |
| 2024/Q4 | 2025-01-22 | -- | ±3.45% | +0.85% (in line) |
| 2024/Q3 | 2024-10-16 | -- | ±3.70% | +1.53% (in line) |
| 2024/Q2 | 2024-07-18 | -- | ±4.49% | -4.40% (in line) |
| 2024/Q1 | 2024-04-17 | -- | ±4.25% | -3.03% (in line) |
| 2023/Q4 | 2024-01-24 | -- | ±3.21% | -2.83% (in line) |
| 2023/Q3 | 2023-10-18 | -- | ±4.44% | +3.71% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-20 09:30:11 · For reference only, not investment advice and not tailored to your situation.
Abbott Laboratories discussion 0 comments